• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Kodiak CMO Steps Down After Phase III Flops for Eye Therapy

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 18, 2023 at 10:33: AM
via Kodiak Sciences’ Chief Medical Officer and Chief Development Officer Jason Ehrlich is stepping down from both of his positions, effective Aug. 25, the company announced in an SEC filing posted Thursday.

article source
 




Top Bottom
Back
Quote